HOME >> BIOLOGY >> NEWS
Homeground ecology 101: Sara Stein to speak at ESA Meeting

On Sunday, August 5, 2001 at 5:00 pm Sara Stein, acclaimed natural science writer and gardener, will speak at the public plenary session of the Ecological Society of America's 86th Annual Meeting. This year's meeting will be held in Madison, Wisconsin August 5-10. In an address entitled, Homeground Ecology 101, Ms. Stein will discuss the importance of connecting ecology to everyday life.

Sara Stein has often been credited with heralding the backyard biodiversity movement of the last decade. A long-time author, Stein began writing about her own land management adventures in the early 1990s. While researching one of her books, she was surprised to realize that many of the once familiar inhabitants of her own property were no longer there. Her research into the reasons for the plants' and animals' absence inspired her well-known volume on the importance of local ecosystems, Noah's Garden. Her work has been compared to that of Aldo Leopold, Rachel Carson, and Henry Thoreau, and her books have often translated some of the toughest ecological science into plain language which has been embraced by non-scientists everywhere.

Ms. Stein's books include My Weeds, a gardener's botany, and Noah's Garden, which relates the ecological restoration of her property in suburban New York. A sequel, Planting Noah's Garden, describes her further pursuits in backyard ecology, and explains how to transform the traditional, lawn-bound home garden into natural habitat. Noah's Children: Restoring the Ecology of Childhood, published this June by Farrar, Strauss, & Giroux, explores a child's need to be connected with natural habitats, for children's own sake and for the sake of all of our futures.


'"/>

Contact: Nadine Lymn
nadine@esa.org
202-833-8773 x205
Ecological Society of America
28-Jun-2001


Page: 1

Related biology news :

1. Lecture on ecology of infectious diseases
2. Better living through urban ecology
3. Wolf reintroduction reshapes Yellowstone ecology
4. Articles on remote sensing in ecology published in BioScience
5. Purdue scientists: Genetically modified fish could damage ecology
6. Earliest evidence of humans affecting aquatic ecology in Canada, United States
7. Alien earthworms changing ecology of Northeast forests
8. IUB scientists to study the ecology of infectious disease -- inside ticks
9. Columbia offers new ecology program in Dominican Republic
10. UCSB ecology center to receive grant
11. US ecology dramatically altered by fertilizers and acid rain

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Homeground ecology Sara Stein speak ESA Meeting

(Date:12/5/2014)... PROVO, Utah , Dec. 4, 2014  Tute ... has raised $2.3 million in Series A1 funding led ... angel investors also participated in the investment round. ... as the healthcare community adopts next-generation sequencing and seeks ... disease," said Reid Robison , MD MBA, and ...
(Date:11/21/2014)... -- Earlier this year Donald Spector , Chairman of ... the most prolific inventors in the world, got a ... to third party agencies. Spector envisioned this technology even ... earliest known patents in this area. Now major technology ... care, elder care and hospital applications. This technology has ...
(Date:11/18/2014)... 17, 2014   News Highlights: ... to develop The Partners Data Lake, an agile ... Data Lake will allow researcher and clinicians to ... and the lives of patients , The ... activities across the Partners system, breaking down physical ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
(Date:12/17/2014)... 2014 Gene synthesis and bioengineering ... entered into a technology access and services agreement ... DNA2.0’s proprietary protein engineering technology, known as “ProteinGPS®” ... are extremely excited that the global leader ADM ... proprietary bioengineering technology has now been validated through ...
(Date:12/17/2014)... -- Vermillion, Inc. (NASDAQ: VRML ), a bio-analytic ... next step in its expanded strategy to rebuild the ... naming of current Chief Operating Officer, Valerie Palmieri ... Chairman of the Board and CEO James LaFrance ... are effective January 1, 2015. "Jim and ...
(Date:12/17/2014)... Md. , Dec. 17, 2014 CASI ... company dedicated to the acquisition, development and commercialization of ... for the global market with a primary commercial focus ... it has been granted a Type C meeting with ... the meeting will be held in February 2015.  During ...
(Date:12/17/2014)... LEXINGTON, Mass. , Dec. 17, 2014   ... a biopharmaceutical company developing therapeutic products for rare disorders, ... Healthcare Conference being held in San Francisco, ... , President and Chief Executive Officer, will present on ... p.m. EST).  The presentation will be webcast live and ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
Cached News: